Comparative features and outcomes of major neurological complications of COVID-19.

Beghi, Ettore; Moro, Elena; Davidescu, Eugenia Irene; Popescu, Bogdan Ovidiu; Grosu, Oxana; Valzania, Franco; Cotelli, Maria Sofia; Kiteva-Trenchevska, Gordana; Zakharova, Maria; Kovács, Tibor; Armon, Carmel; Brola, Waldemar; Yasuda, Clarissa Lin; Maia, Luís F; Lovrencic-Huzjan, Arijana; de Seabra, Mafalda Maria Laracho; Avalos-Pavon, Rafael; Aamodt, Anne Hege; Meoni, Sara; Gryb, Victoria; ... (2023). Comparative features and outcomes of major neurological complications of COVID-19. European journal of neurology, 30(2), pp. 413-433. Wiley 10.1111/ene.15617

Text Beghi__2022__Comparative_features_and_outcomes_of_major_neurological_complications_of_COVID_19.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (481kB) | Request a copy

BACKGROUND AND PURPOSE

The aim of this study was to assess the neurological complications of SARS-CoV-2 infection and compare phenotypes and outcomes in infected patients with and without selected neurological manifestations.

METHODS

The data source was a registry established by the European Academy of Neurology during the first wave of the COVID-19 pandemic. Neurologists collected data on patients with COVID-19 seen as in- and outpatients and in emergency rooms in 23 European and seven non-European countries. Prospective and retrospective data included patient demographics, lifestyle habits, comorbidities, main COVID-19 complications, hospital and intensive care unit admissions, diagnostic tests, and outcome. Acute/subacute selected neurological manifestations in patients with COVID-19 were analysed, comparing individuals with and without each condition for several risk factors.

RESULTS

By July 31, 2021, 1523 patients (758 men, 756 women, and nine intersex/unknown, aged 16-101 years) were registered. Neurological manifestations were diagnosed in 1213 infected patients (79.6%). At study entry, 978 patients (64.2%) had one or more chronic general or neurological comorbidities. Predominant acute/subacute neurological manifestations were cognitive dysfunction (N = 449, 29.5%), stroke (N = 392, 25.7%), sleep-wake disturbances (N = 250, 16.4%), dysautonomia (N = 224, 14.7%), peripheral neuropathy (N = 145, 9.5%), movement disorders (N = 142, 9.3%), ataxia (N = 134, 8.8%), and seizures (N = 126, 8.3%). These manifestations tended to differ with regard to age, general and neurological comorbidities, infection severity and non-neurological manifestations, extent of association with other acute/subacute neurological manifestations, and outcome.

CONCLUSIONS

Patients with COVID-19 and neurological manifestations present with distinct phenotypes. Differences in age, general and neurological comorbidities, and infection severity characterize the various neurological manifestations of COVID-19.

Interest & Impact

Downloads

1 since deposited on 09 Jan 2023
1 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item